BOVI, Michele
 Distribuzione geografica
Continente #
EU - Europa 2.612
NA - Nord America 2.396
AS - Asia 1.909
SA - Sud America 250
AF - Africa 59
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.243
Nazione #
US - Stati Uniti d'America 2.329
RU - Federazione Russa 1.008
CN - Cina 710
SG - Singapore 615
GB - Regno Unito 410
IT - Italia 354
BR - Brasile 198
VN - Vietnam 196
DE - Germania 186
FR - Francia 136
SE - Svezia 131
HK - Hong Kong 126
FI - Finlandia 125
IE - Irlanda 114
KR - Corea 54
CA - Canada 40
IN - India 35
ID - Indonesia 34
JP - Giappone 34
EG - Egitto 29
UA - Ucraina 27
AR - Argentina 23
MX - Messico 22
ES - Italia 21
IR - Iran 20
BE - Belgio 18
AU - Australia 16
PK - Pakistan 14
TR - Turchia 14
AT - Austria 13
ZA - Sudafrica 13
BD - Bangladesh 12
PL - Polonia 12
DK - Danimarca 9
EC - Ecuador 9
IQ - Iraq 9
NL - Olanda 8
PT - Portogallo 8
MY - Malesia 7
CO - Colombia 6
MA - Marocco 6
UZ - Uzbekistan 6
CH - Svizzera 5
CL - Cile 4
LT - Lituania 4
LU - Lussemburgo 4
RO - Romania 4
TW - Taiwan 4
AZ - Azerbaigian 3
NO - Norvegia 3
AL - Albania 2
BO - Bolivia 2
BY - Bielorussia 2
ER - Eritrea 2
ET - Etiopia 2
HU - Ungheria 2
IL - Israele 2
KW - Kuwait 2
MD - Moldavia 2
NP - Nepal 2
PE - Perù 2
PY - Paraguay 2
SA - Arabia Saudita 2
UG - Uganda 2
UY - Uruguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
BZ - Belize 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MU - Mauritius 1
NI - Nicaragua 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SD - Sudan 1
SI - Slovenia 1
SZ - Regno dello Swaziland 1
TH - Thailandia 1
Totale 7.243
Città #
Moscow 359
Southend 326
Chandler 304
Singapore 300
Dearborn 225
Jacksonville 201
Verona 184
Woodbridge 179
Ashburn 156
Dallas 142
Hong Kong 123
Ann Arbor 119
Dublin 114
Beijing 91
Dong Ket 68
Jinan 63
Wilmington 57
New York 56
Shenyang 50
Houston 49
Lawrence 47
Princeton 47
Los Angeles 46
Munich 45
Ho Chi Minh City 40
The Dalles 35
Nanjing 32
Turku 31
Guangzhou 29
Jakarta 29
Tianjin 29
Hangzhou 24
São Paulo 23
Hebei 22
Buffalo 21
Helsinki 21
Ningbo 20
Tokyo 20
Milan 19
Haikou 18
Brussels 17
Seoul 17
Taiyuan 17
Jiaxing 16
Nanchang 16
Changsha 15
Redondo Beach 14
Hanoi 13
Zhengzhou 13
Mexico City 12
Santa Clara 12
Taizhou 12
Boardman 11
Norwalk 11
Toronto 11
Cairo 10
Chicago 10
Council Bluffs 10
Falkenstein 10
Lanzhou 10
Warsaw 10
Montreal 9
Vienna 9
Catanzaro 8
Cavallino 8
Falls Church 8
Frankfurt am Main 8
London 8
Sindelfingen 8
Columbus 7
East Setauket 7
Nuremberg 7
Redwood City 7
San Francisco 7
Strasbourg 7
Cagliari 6
Chennai 6
Karlslunde 6
Lancaster 6
Renton 6
Seattle 6
Stockholm 6
Tashkent 6
Tower Hamlets 6
Brisbane 5
Bruneck 5
Gwanak-gu 5
Islamabad 5
Johannesburg 5
Kent 5
Maceió 5
Manchester 5
Mashhad 5
Rome 5
Ankara 4
Baghdad 4
Boston 4
Bremen 4
Brooklyn 4
Campinas 4
Totale 4.267
Nome #
Arundo donax lectin 371
Arundo donax lectin 303
Structural studies of human acidic fibroblast-growth factor (FGF1) mutants with a probable anticancer activity 264
Unraveling the antitumoral properties of Arundo donax lectin 242
MOLECULARLY IMPRINTED NANOPARTICLES FOR HEPCIDIN CAPTURE: A SYNTHETIC ALTERNATIVE TO NATURAL ANTIBODIES 202
Runx2 downregulation, migration and proliferation inhibition in melanoma cells treated with BEL β-trefoil 201
BEL β-trefoill. A novel lectin with antineoplastic properties in king bolete (Boletus edulis) mushrooms 200
TREATMENT OF SKELETAL DISEASES WITH A NATURALLY DERIVED ANTIOXIDANT AND BISPHOSPHONATE EMBEDDED NANOPARTICLES 190
Purification and structural studies of a Tremella fuciformis mushroom lectin 177
Ketamine nano-delivery based on poly-lactic-co-glycolic acid (PLGA) nanoparticles 177
Inclusion of α-bisabolol into PLGA nanoparticles enhances its pro-apoptotic activity in human tumoral pancreatic cells. 176
High resolution structures of mutants of residues that affect access to the ligand-binding cavity of human lipocalin-type prostaglandin D Synthase 170
Light dependent redox catalysis by Photosystem I complexes encapsulated in organic nanoparticles 167
BEL β-TREFOIL. A NOVEL LECTIN WITH ANTITUMORAL PROPERTIES IN KING BOLETE (BOLETUS EDULIS) MUSHROOMS 166
Purification and structural studies of a Tremella fuciformis mushroom lectin 163
Clodronate as a Therapeutic Strategy against Osteoarthritis 159
Ligand Binding to Chicken Liver Basic Fatty acid-Binding Protein. An X-ray Crystallography Study 157
Expression, purification and structural characterization of human lipocalin-type prostaglandin D synthase (L-PGDS) 155
Targeted PLGA nanocarriers for brain drug delivery 154
Inclusion into PLGA nanoparticles greatly improves the effectiveness of α-bisabolol to inhibit human Dendritic Cell pro-inflammatory activity 152
Structural studies of POL (Pleurotus ostreatus Lectin), a fungal lectin of medical interest 150
Novel functionalization strategies of polymeric nanoparticles as carriers for brain medications 149
Testing nanocarriers for targeted brain drug delivery. 148
Preparation and characterization of silica nanoparticles conjugated with a protein that specifically recognizes human cancer cells 146
Surface plasmon resonance based on molecularly imprinted nanoparticles for the picomolar detection of the iron regulating hormone Hepcidin-25 145
Structural and biophysical studies on the lectin domain of GalNAc-T6 for therapeutic applications 145
Three-dimensional structure and ligand-binding site of carp Fishelectin (FEL) 143
Structural Studies of Antineoplastic Lectins in Edible Mushrooms 141
Nanoparticles in the brain parenchyma: a friendly relationship? 141
Structural changes in the BH3 domain of SOUL protein upon interaction with the anti-apoptotic protein Bcl-xL 140
The inclusion into PLGA nanoparticles enables a-bisabolol to efficiently inhibit the human dendritic cell proinflammatory activity 132
Crystallographic studies on carp Fishelectin (FEL) 128
Three-dimensional structure and ligand-binding site of carp fishelectin (FEL) 125
Structural studies of human acidic fibroblast growth factor mutants to be used in anticancer therapy 125
Crystallographic studies on carp Fishelectin (FEL) 122
High resolution structures of mutants of residues that affect access to the ligand-binding cavity of human lipocalin-type prostaglandin D synthase 120
Encapsulation of Photosystem I in organic microparticles increases its photochemical activity and stability for ex vivo photocatalysis 116
Purification and Characterization of a New Lectin From the Edible Mushroom Boletus edulis with Antiproliferative Effect on Tumor Cell Lines 112
Stealth silica nanoparticles for theranostic applications 111
Structural studies of antineoplastic lectins in edible mushrooms 109
Structural characterization and interaction studies of humanlipocalin-type prostaglandin D synthase (L-PGDS) 106
Structural characterization and interaction studies of human lipocalin-type prostaglandin D synthase (L-PGDS) 103
Structure of a lectin with antitumoral properties in king bolete (Boletus edulis) mushrooms 99
Structural characterization and interaction studies of human lipocalin-type prostaglandin D synthase (L-PGDS) 95
”SPR biosensors and “natural hepcidin receptor” immobilization for hepcidin-25 determination in serum.” 94
STRUCTURAL CHARACTERIZATION OF HUMAN LIPOCALIN-TYPEPROSTAGLANDIN D SYNTHASE (L-PGDS) 87
Essential oil-based emulsions reduce bacterial canker on kiwifruit plants acting as antimicrobial and antivirulence agents against Pseudomonas syringae pv. actinidiae 77
Structure and properties of the oyster mushroom (Pleurotus ostreatus) lectin (POL) 75
Totale 7.330
Categoria #
all - tutte 21.830
article - articoli 5.950
book - libri 0
conference - conferenze 14.830
curatela - curatele 0
other - altro 476
patent - brevetti 0
selected - selezionate 0
volume - volumi 574
Totale 43.660


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021209 0 0 0 0 0 33 5 14 16 8 27 106
2021/2022442 41 174 3 10 8 16 6 16 16 17 34 101
2022/2023839 66 98 78 126 72 193 11 50 104 7 22 12
2023/2024486 12 41 30 31 42 91 59 40 3 31 74 32
2024/20251.148 55 66 52 186 91 45 53 49 165 61 101 224
2025/20262.195 229 189 220 551 832 174 0 0 0 0 0 0
Totale 7.330